John Burkhardt, left, senior vice president of drug safety R&D and head of the Pfizer Groton site speaks at a press conference at Pfizer Groton on the companies research to develop a vaccine for COVID-19, as Connecticut Gov. Ned Lamont stands by to answer questions Wednesday, July 22, 2020, in Groton, Conn. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Stew Milne)
GROTON — If and when a coronavirus vaccine becomes available, Gov. Ned Lamont is leaning toward having essential workers vaccinated first in Connecticut. Lamont visited the Groton research and development center of Pfizer Inc. Wednesday after the announcement that the company and German partner BioNTech SE inked a $1.95 billion deal with the Trump administration […]
LOG IN REQUIRED
LOG IN to your accountREGISTER to access your 5 FREE ARTICLES a month.Print Subscribers click here to ACTIVATE your accessPURCHASE a Digital subscription
Use the form below for instant purchase of an online subscription.
Register and Purchase a Subscription